… the international Berlin-Frankfurt-Münster (I-BFM) AML study … aim of this study was to
describe the biological and clinical … KMT2A rearrangements, t(16;21)(q22;q22) and inv(16)(p13;q22)…

… Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity:
a collaborative study by the InternationalBerlin-Frankfurt-Munster AML-study group. Blood. …

… different systems exist for subclassification of acute myeloid … 2 Studies on clinical
characteristics and outcome in pediatric … A total of 159 cases of AML carrying the t(8;16)(p11;p13) …

… adult and pediatric patients [1, 3,4,5,6,7,8,9]. AML with … greatly in different reports and in
different age groups. In this … The clinical features are summarized in Table 1. A total of 15 …

… International Berlin-Frankfurt-Munster (I-BFM) AML study group reviewed 62 patients with
t(8; 16)(p11.2;p13) and compared them with a pediatric AML reference cohort [3]. Nearly all …

… Amongst pediatric AML with t(8;16) (p11;p13), as many as 70% of cases reported show … In
conclusion, AML with t(8;16)(p11;p13) is a rare yet distinct clinical and pathological entity that …

… (AML) is a rare subgroup of AML of pediatric patients under … in AML associated with t(8;16)(p11;p13)
[15,16]. These … Some collaborative groups have defined AML<1 year old as a …

… child with congenital acute myeloid leukemia (AML) with t(8 ; … ; p13) are a distinct clinical
and biological entity. For example… the Japanese Childhood AML Cooperative Study Group. J …

… by unique morphologic and clinical findings in acute myeloid … and pediatric t(8;16)(p11;p13)-AML
patients show similar clinical … Firm biological data in t(8;16)(p11;p13)-AML are lacking …

… with distinct clinical and morphologic features and poor prognosis. AML with t(8;16) translocation
can occur in adults or children. … cooperative mutations are common in AML with t(8;16) …